Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer Study

BACKGROUND: We have previously reported that expression of the RNA- and DNA-binding protein RBM3 is associated with a good prognosis in breast cancer and ovarian cancer. In this study, the prognostic value of immunohistochemical RBM3 expression was assessed in incident cases of malignant melanoma fr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jonsson, Liv, Bergman, Julia, Nodin, Björn, Manjer, Jonas, Pontén, Fredrik, Uhlén, Mathias, Jirström, Karin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3156749/
https://ncbi.nlm.nih.gov/pubmed/21777469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-9-114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados